Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Z. Pavelek · SciRah

Researcher profile · Semantic Scholar

Z. Pavelek

Share profile

Z. Pavelek — researcher profile on SciRah

h-index: 11
Works: 64
Citations: 348

Most-cited papers

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
J. Masopust, D. Protopopová, M. Vališ, Z. Pavelek +1 more
2018Neuropsychiatric Disease and Treatment96 citations Open access
Semantic Scholar
Deep Learning for Accelerometric Data Assessment and Ataxic Gait Monitoring
A. Procházka, Ondrej Dostal, P. Cejnar, Hagar I. Mohamed +3 more
2021IEEE transactions on neural systems and rehabilitation engineering30 citations Open access
Semantic Scholar
Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial
F. Musil, J. Pokladnikova, Z. Pavelek, Bo Wang +2 more
2018Neuropsychiatric Disease and Treatment30 citations Open access
Semantic Scholar
The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine
Z. Pavelek, O. Souček, J. Krejsek, L. Sobíšek +4 more
2020Scientific Reports21 citations Open access
Semantic Scholar
Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
Z. Pavelek, O. Vyšata, V. Tambor, K. Pimková +4 more
2016Biomedical Reports19 citations Open access
Semantic Scholar
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis
M. Vališ, A. Achiron, Hans-Peter Hartung, J. Mareš +5 more
2023Drugs in R&D16 citations Open access
Semantic Scholar
The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers
M. Vališ, D. Herman, N. Váňová, J. Masopust +7 more
2019Frontiers in Pharmacology16 citations Open access
Semantic Scholar
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries.
T. Hrnciarova, J. Drahota, T. Spelman, J. Hillert +17 more
2023Multiple Sclerosis and Related Disorders15 citations
Semantic Scholar
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021.
D. Stastna, J. Drahota, Michal Lauer, Aneta Mazouchova +17 more
2023Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia13 citations Open access
Semantic Scholar
In Silico Studies of Potential Selective Inhibitors of Thymidylate Kinase from Variola virus
Danielle R. Garcia, F. R. Souza, A. P. Guimarães, M. Vališ +4 more
2021Pharmaceuticals13 citations Open access
Semantic Scholar
An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart®
M. Vališ, Jana Šarláková, S. Halúsková, B. Klimova +6 more
2020Expert Opinion on Drug Delivery11 citations
Semantic Scholar
Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase
Z. Pavelek, F. Angelucci, O. Souček, J. Krejsek +6 more
2020Journal of Clinical Medicine9 citations Open access
Semantic Scholar
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability
Jessica Shipley, Heidi N. Beadnall, Paul G. Sanfilippo, Wei Z. Yeh +35 more
2025JAMA Network Open6 citations Open access
Semantic Scholar
The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease.
M. Vališ, Alžběta Dlabková, J. Hort, F. Angelucci +5 more
2023Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie5 citations Open access
Semantic Scholar
Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry
M. Vališ, Z. Pavelek, Michal Novotný, B. Klimová +11 more
2022Frontiers in Neurology5 citations Open access
Semantic Scholar
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry
Pavel Potuznik, J. Drahota, D. Horáková, Marek Peterka +17 more
2024Journal of Central Nervous System Disease4 citations Open access
Semantic Scholar
DORADA adherence study: full view into RebiSmart subdomains parameters in multiple sclerosis treatment
Z. Pavelek, Michal Novotný, B. Klimova, Marek Peterka +3 more
2021Current Medical Research and Opinion4 citations Open access
Semantic Scholar
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
Z. Pavelek, L. Sobíšek, Jana Šarláková, Pavel Potuznik +12 more
2021Frontiers in Neurology4 citations Open access
Semantic Scholar
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
M. Vališ, P. Ryška, S. Halúsková, B. Klimova +1 more
2020BMC Neurology4 citations Open access
Semantic Scholar
Autoimmune and limbic encephalitis: case series with some atypical variables in clinical practice
P. Štourač, J. Bednářová, Pavel Zicháček, Z. Čermáková +2 more
2021Neurological Sciences3 citations
Semantic Scholar
The direct costs of multiple sclerosis—study in the Czech Republic
P. Marešová, M. Vališ, Michal Novotný, Z. Pavelek +1 more
2018Neurological Sciences3 citations
Semantic Scholar
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)
V. Jokubaitis, R. Alroughani, A. Altintas, S. Eichau +36 more
2025Multiple Sclerosis2 citations Open access
Semantic Scholar
Quantiferon Monitor Testing Sheds Light on Immune System Disparities between Multiple Sclerosis Patients and Healthy Individuals
Ilona Součková, Ondřej Souček, J. Krejsek, O. Vyšata +5 more
2024International Journal of Molecular Sciences2 citations Open access
Semantic Scholar
Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor
Z. Pavelek, O. Souček, J. Krejsek, Ilona Sejkorova +8 more
2023Journal of Immunological Research2 citations Open access
Semantic Scholar
Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groups.
Z. Pavelek, Michal Novotný, O. Souček, J. Krejsek +7 more
2021Multiple Sclerosis and Related Disorders2 citations
Semantic Scholar
Monitoring of Lymphocyte Populations During Treatment with Interferon-β-1b to Predict Multiple Sclerosis Disability Progression
M. Vališ, O. Vyšata, Luláš Sobíšek, B. Klimova +3 more
2019Journal of Interferon and Cytokine Research2 citations
Semantic Scholar
Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study.
C. Zecca, Z. Pavelek, K. Přikrylová, Mascia Ghielmetti +2 more
2019Multiple Sclerosis and Related Disorders2 citations
Semantic Scholar
Encephalitis with anti-NMDA receptor antibodies: paraneoplastic or non-paraneoplastic?
J. Masopust, A. Tvaroh, Z. Pavelek, M. Vališ
2018Neuro - endocrinology letters2 citations
Semantic Scholar
Lymphocyte populations and their change during five-year glatiramer acetate treatment.
Z. Pavelek, O. Vyšata, L. Sobíšek, B. Klimova +5 more
2018Neurologia i Neurochirurgia Polska2 citations
Semantic Scholar
Lymphocytes in the treatment with interferon beta-1 b.
Z. Pavelek, O. Vyšata, B. Klimova, C. Andrys +2 more
2017Multiple Sclerosis and Related Disorders2 citations
Semantic Scholar
A comparison of efficacy of subcutaneous interferon β-1a 44 μg, dimethyl fumarate and fingolimod in the real-life clinical practise – a multicenter observational study
Z. Pavelek, L. Sobíšek, M. Vališ
20172 citations
Semantic Scholar
Exploring the Prognostic Role of Neurofilaments and SEMA3A in Multiple Sclerosis Progression
Z. Pavelek, Ondřej Souček, J. Krejsek, Ilona Součková +4 more
2025International Journal of Molecular Sciences1 citations
Semantic Scholar
Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis
Marek Peterka, M. Vališ, O. Souček, J. Krejsek +6 more
2023European Neurology1 citations Open access
Semantic Scholar
Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes.
P. Štourač, J. Bednářová, Z. Pavelek, M. Vališ
2021Neurologia i Neurochirurgia Polska1 citations Open access
Semantic Scholar
Multiple sclerosis: treatment, monitoring, activity and disability
Z. Pavelek, M. Vališ
2018Neurologie pro praxi1 citations Open access
Semantic Scholar
Registration and analysis of retinal images for diagnosis and treatment monitoring
A. Procházka, O. Vyšata, J. Vavrycukova, P. Cejnar +2 more
2014International Workshop on Computational Intelligence for Multimedia Understanding1 citations
Semantic Scholar
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study
Izanne Roos, S. Sharmin, D. Horáková, Eva Kubala Havrdová +85 more
2026Journal of Neurology Neurosurgery & Psychiatry0 citations Open access
Semantic Scholar
Predictors of relapse following transition to ofatumumab in relapsing-remitting multiple sclerosis.
P. Reardon, Michael Zhong, D. Horáková, Allan G. Kermode +23 more
2026Multiple Sclerosis and Related Disorders0 citations Open access
Semantic Scholar
Is Cladribine a Suitable Strategy after Natalizumab in MS? Real-world Outcomes (P4-20.007)
M. Vachova, D. Stastna, J. Drahota, Pavel Potuznik +17 more
2026Neurology0 citations
Semantic Scholar
Reasons for Treatment Continuation with Cladribine Tablets Beyond Year 4: Initial Real-World Insights from the CLADRISE Study in the Czech ReMuS Registry
G. Fištravec, J. Drahota, D. Horáková, E. Havrdova +16 more
2026Multiple Sclerosis and Related Disorders0 citations
Semantic Scholar
Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment
S. Halúsková, Martin Vališ, Z. Pavelek
2026Ceská a slovenská neurologie a neurochirurgie0 citations
Semantic Scholar
Five-by-Five: Nationwide Real-world Outcomes after ≥Five Years of Cladribine With an Age ≥50 Subanalysis (P2-20.006)
D. Stastna, M. Vachova, J. Drahota, Pavel Potuznik +17 more
2026Neurology0 citations
Semantic Scholar
Posttraumatic headache
Z. Pavelek
2025Neurologie pro praxi0 citations
Semantic Scholar
From Trials to Real-world Data: National Insights on Cladribine Tablets in Multiple Sclerosis After Four Years and Beyond (P8-1.009)
D. Stastna, G. Fištravec, J. Drahota, I. Menkyova +17 more
2025Neurology0 citations
Semantic Scholar
Long‑term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data
Z. Pavelek, M. Vališ
2023Neurologie pro praxi0 citations
Semantic Scholar
Corrigendum to "The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease" [Biomed. Pharmacother. 159 (2023) 114223].
M. Vališ, Alžběta Dlabková, J. Hort, F. Angelucci +5 more
2023Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie0 citations Open access
Semantic Scholar
Diagnosis of multiple sclerosis: can errors and mistakes occur?
Z. Pavelek, M. Vališ
2023Neurologie pro praxi0 citations
Semantic Scholar
esponse relating to the article "Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes".
P. Štourač, J. Bednářová, Z. Pavelek, M. Vališ
2022Neurologia i Neurochirurgia Polska0 citations Open access
Semantic Scholar
Etiopathogenesis and diagnostics of progressive multifocal leukoencephalopathy in patients treated with natalizumab
P. Štourač, J. Bednářová, Z. Pavelek
20210 citations
Semantic Scholar
Pharmacotherapy of non-Alzheimer's types of dementia
M. Vališ, J. Masopust, Z. Pavelek
20200 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Vališ×32
Invite
M. Vališ — researcher profile on SciRah
P. Štourač×24
Invite
P. Štourač — researcher profile on SciRah
Marek Peterka×18
Invite
Marek Peterka — researcher profile on SciRah
R. Ampapa×12
Invite
R. Ampapa — researcher profile on SciRah

×11

Invite

Eva Recmanová — researcher profile on SciRah

Invite

B. Klimova — researcher profile on SciRah

Invite

K. Kuča — researcher profile on SciRah

Invite

O. Vyšata — researcher profile on SciRah

L. Sobíšek×9

Invite

L. Sobíšek — researcher profile on SciRah

D. Horáková×9

Invite

D. Horáková — researcher profile on SciRah

Michal Novotný×8

Invite

Michal Novotný — researcher profile on SciRah

S. Halúsková×7

Invite

S. Halúsková — researcher profile on SciRah